DE69612568D1 - 17-seitenkette-alknyl- und 20-oxopregna-derivate von vitamin d, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon - Google Patents

17-seitenkette-alknyl- und 20-oxopregna-derivate von vitamin d, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon

Info

Publication number
DE69612568D1
DE69612568D1 DE69612568T DE69612568T DE69612568D1 DE 69612568 D1 DE69612568 D1 DE 69612568D1 DE 69612568 T DE69612568 T DE 69612568T DE 69612568 T DE69612568 T DE 69612568T DE 69612568 D1 DE69612568 D1 DE 69612568D1
Authority
DE
Germany
Prior art keywords
derivatives
oxopregna
alknyl
vitamin
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69612568T
Other languages
English (en)
Other versions
DE69612568T2 (de
Inventor
Henry Hesse
Murdoch Pechet
Katugam Setty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Institute for Medicine and Chemistry Inc
Original Assignee
Research Institute for Medicine and Chemistry Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Institute for Medicine and Chemistry Inc filed Critical Research Institute for Medicine and Chemistry Inc
Publication of DE69612568D1 publication Critical patent/DE69612568D1/de
Application granted granted Critical
Publication of DE69612568T2 publication Critical patent/DE69612568T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
DE69612568T 1995-12-21 1996-12-23 17-seitenkette-alknyl- und 20-oxopregna-derivate von vitamin d, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon Expired - Fee Related DE69612568T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9526208.5A GB9526208D0 (en) 1995-12-21 1995-12-21 Chemical compounds
PCT/GB1996/003218 WO1997023453A1 (en) 1995-12-21 1996-12-23 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d, methods for their production and pharmaceutical compositions thereof

Publications (2)

Publication Number Publication Date
DE69612568D1 true DE69612568D1 (de) 2001-05-23
DE69612568T2 DE69612568T2 (de) 2001-09-06

Family

ID=10785847

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69612568T Expired - Fee Related DE69612568T2 (de) 1995-12-21 1996-12-23 17-seitenkette-alknyl- und 20-oxopregna-derivate von vitamin d, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon

Country Status (21)

Country Link
US (2) US6372926B2 (de)
EP (1) EP0874815B1 (de)
JP (1) JP2000503636A (de)
KR (1) KR19990076664A (de)
CN (1) CN1086694C (de)
AT (1) ATE200663T1 (de)
AU (1) AU710680B2 (de)
CA (1) CA2241011A1 (de)
CZ (1) CZ290930B6 (de)
DE (1) DE69612568T2 (de)
DK (1) DK0874815T3 (de)
ES (1) ES2155948T3 (de)
GB (1) GB9526208D0 (de)
GR (1) GR3036132T3 (de)
HU (1) HUP9903786A3 (de)
IL (1) IL125027A0 (de)
NO (1) NO982816L (de)
NZ (1) NZ324775A (de)
PT (1) PT874815E (de)
WO (1) WO1997023453A1 (de)
ZA (1) ZA9610874B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003087048A2 (en) * 2002-04-11 2003-10-23 Instytut Farmaceutyczny Preparation of 24 alkyl analogs of cholecalciferol and non-racemic compounds
US7253293B2 (en) * 2004-01-06 2007-08-07 Andrzej Slominski Enzymatic method to produce 7-dehydropregnenolone, vitamin D3-like compounds and derivatives thereof
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
US20080280860A1 (en) * 2005-03-23 2008-11-13 Bioxell S.P.A. Use of Vitamin D Compounds to Treat Endometriosis
TW200714580A (en) * 2005-10-14 2007-04-16 Formosa Lab Inc Process for preparing vitamin D analogs
SG173119A1 (en) * 2009-01-27 2011-08-29 Berg Biosystems Llc Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
BR112012003372A2 (pt) 2009-08-14 2019-09-24 Berg Biosystems Llc vitamina d3 e análogos da mesma para o tratamento de alopecia.
JP5563324B2 (ja) * 2010-02-03 2014-07-30 フォーモサ・ラボラトリーズ・インコーポレーテッド マキサカルシトール中間体およびその製造方法
EP3003497B1 (de) 2013-05-29 2024-02-14 BPGbio, Inc. Verhinderung oder verringerung von chemotherapieinduzierter alopezie mit vitamin d

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034543B2 (ja) 1977-07-01 1985-08-09 中外製薬株式会社 ビタミンd誘導体
GB9214202D0 (en) * 1992-07-03 1992-08-12 Leo Pharm Prod Ltd Chemical compounds
GB9220439D0 (en) * 1992-09-28 1992-11-11 Leo Pharm Prod Ltd Chemical compounds
US5397776A (en) * 1993-08-20 1995-03-14 Wisconsin Alumni Research Foundation Vitamin D compounds with anti-progesterone activity

Also Published As

Publication number Publication date
ZA9610874B (en) 1997-06-18
NZ324775A (en) 1999-02-25
CZ194798A3 (cs) 1998-11-11
JP2000503636A (ja) 2000-03-28
CN1086694C (zh) 2002-06-26
ES2155948T3 (es) 2001-06-01
GR3036132T3 (en) 2001-09-28
US20020010163A1 (en) 2002-01-24
NO982816L (no) 1998-08-21
CN1209120A (zh) 1999-02-24
GB9526208D0 (en) 1996-02-21
US6372926B2 (en) 2002-04-16
CA2241011A1 (en) 1997-07-03
EP0874815A1 (de) 1998-11-04
US20020188142A1 (en) 2002-12-12
EP0874815B1 (de) 2001-04-18
NO982816D0 (no) 1998-06-18
AU1202597A (en) 1997-07-17
ATE200663T1 (de) 2001-05-15
PT874815E (pt) 2001-07-31
IL125027A0 (en) 1999-01-26
KR19990076664A (ko) 1999-10-15
HUP9903786A3 (en) 2000-09-28
WO1997023453A1 (en) 1997-07-03
DK0874815T3 (da) 2002-03-04
CZ290930B6 (cs) 2002-11-13
DE69612568T2 (de) 2001-09-06
AU710680B2 (en) 1999-09-30
HUP9903786A2 (hu) 2000-03-28

Similar Documents

Publication Publication Date Title
DE69627853D1 (de) Verwendung von squalamin zur herstellung eines arzneimittels zur inhibierung von nhe
DK0982032T3 (da) Anvendelse af en sulfamatesterholdig sterolforbindelse til fremstilling af et lægemiddel til kontrol af østrogenproduktion
AR001440A1 (es) Nuevos taxoides, su preparación y composiciones farmacéuticas que los contienen.
DE69612568D1 (de) 17-seitenkette-alknyl- und 20-oxopregna-derivate von vitamin d, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon
DE69103089D1 (de) Alicyclische Verbindung enthaltende Komposition, Verfahren für ihre Herstellung, polymerisierbare Komposition und photopolymerisierbare Komposition.
DE69823662D1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
ATE152118T1 (de) Kardioaktive 17b-(3-furyl) und 17b-(4- pyridazinyl)-5beta, 14beta-androstan derivate, verfahren zu ihrer herstellung und pharmazeutische präparate davon
ES2160308T3 (es) Nuevos derivados amino-metil-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ATE197457T1 (de) Verbrückte cyclopentadienylmagnesium-verbindungen und verfahren zu ihrer herstellung und ihre verwendung zur herstellung von metallocenen
ATE401303T1 (de) Verfahren zur herstellung von ed-71
ES2182090T3 (es) Nuevos derivados de pirrol.
DE58900439D1 (de) N-substituierte-n-nitroso-aminoacetonitrile, verfahren zu ihrer herstellung und ihre verwendung.
FI951760A0 (fi) Gestageenisesti vaikuttavat 19,11-silloitetut 4-estreenit
DE59607683D1 (de) Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
ATE194357T1 (de) 21-(2-oxo-tetrahydrofuran)-thio pregnan derivative, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon
NO20022896L (no) Substituerte 1- og 2-naftol mannich baser
ATE201414T1 (de) Sphingoid lipidverbindungen, ein verfahren zur ihrer herstellung und kosmetische und dermopharmazeutische verwendungen davon
IT1269584B (it) Procedimento per la preparazione di derivati di 5,6-diidrossi- 2-ammino-1,2,3,4- tetraidronaftalene
ATE183512T1 (de) Kardioaktive 17-hydroxyiminoalkyl- und 17- hydroxyiminomethylalkenyl-steroid-derivate, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon
ATE189887T1 (de) Vitamin-d-derivat und verfahren zu seiner herstellung
DK0820435T3 (da) Fremgangsmåde til fremstilling af i det væsentlige rene isomerer af alpha-bisoximer
ATE195529T1 (de) 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio- androstane derivate (17beta-(gamma-buttersäure- lacton)-thio derivate) zur behandlung von entzündungen, pharmazeutische präparate davon und ein verfahren zu ihrer herstellung
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
AR003967A1 (es) Epimeros de (22r)-n-(1,1,1-trifluoro-2-fenilprop-2-il)-3-oxo-4-aza-5alfa- androst-1-eno-17beta-carboxamida, un proceso para su preparacion y unacomposicion farmaceutica que los comprenden.
DE3868948D1 (de) 4,4-dimethyltetrahydropyr-2-on-derivate, verfahren zu ihrer herstellung und ihre verwendung zur synthese von pyretrinverbindungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee